12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 298 participants.

Also called NCT02647320

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 298 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02647320
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02647320. Randomized; quadruple masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2017-01-31 (actual). Results posted on 2018-05-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Sitagliptin 100 mg
Intervention (Drug)
DS-8500a 25mg
Intervention (Drug)
Placebo Tablet
Intervention (Drug)
Placebo Capsule
Lead sponsor
Daiichi Sankyo (class: industry)

Record details

Record id
cardio:ct-nct02647320
Content hash
bd2ea30bb96780ab00f6b0b46ebe8135ee49c93ef7f7269dd2701526025c8e59